Forbion Capital Fund IV Cooperatief U.A. 的 Form 4 申報
NewAmsterdam Pharma Co N.V.NAMS，2024/12/26 申報
- 申報編號
- 0000950170-24-140408
- 申報時間
- 2024/12/26 16:15 ET
- 交易日
- 2024/12/20-12/24
- 申報延遲
- 6 天
- 10b5-1 計畫
- 有勾選
這份申報列了 4 筆非衍生性交易。公開市場賣出合計 $233.0 萬。交易後 6 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Forbion Capital Fund IV Cooperatief U.A.CIK 0001823747 | 持股 10% 以上大股東 |
| Forbion Growth Opportunities Fund I Cooperatief U.A.CIK 0001911047 | 持股 10% 以上大股東 |
| Forbion Growth Management B.V.CIK 0001918318 | 持股 10% 以上大股東 |
| Forbion IV Management B.V.CIK 0002005384 | 持股 10% 以上大股東 |
| ForGrowth NAP B.V.CIK 0002005407 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/12/20 | Ordinary Shares | S賣出處分 | −44,143 | $25.53F2,F3 | −$1,126,992.86 | 10,807,853 | 間接 | |
| 2024/12/20 | Ordinary Shares | S賣出處分 | −5,629 | $26.13F5 | −$147,071.13 | 10,802,224 | 間接 | |
| 2024/12/23 | Ordinary Shares | S賣出處分 | −25,132 | $25.49F6 | −$640,624.73 | 10,777,092 | 間接 | |
| 2024/12/24 | Ordinary Shares | S賣出處分 | −16,164 | $25.66F7 | −$414,831.28 | 10,760,928 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents 19,388 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 24,755 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.99. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,807,853 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,155,680 are held by PoolCo and are allocated to ForGrowth,
表 I 有 1 筆交易的價格引用這則附註。
- F3
(Continued from footnote 2) of which 4,094,330 shares are beneficially owned by Forbion Growth I and 6,061,350 shares are beneficially owned by Forbion IV.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents 2,472 shares sold on behalf of Forbion Growth I and 3,157 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.02 to $26.205. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,802,224 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,150,051 are held by PoolCo and are allocated to ForGrowth, of which 4,091,858 shares are beneficially owned by Forbion Growth I and 6,058,193 shares are beneficially owned by Forbion IV.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents 11,038 shares sold on behalf of Forbion Growth I and 14,094 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.835. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,777,092 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,124,919 are held by PoolCo and are allocated to ForGrowth, of which 4,080,820 shares are beneficially owned by Forbion Growth I and 6,044,099 shares are beneficially owned by Forbion IV.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents 7,099 shares sold on behalf of Forbion Growth I and 9,065 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.23 to $26.00. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,760,928 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,108,755 are held by PoolCo and are allocated to ForGrowth, of which 4,073,721 shares are beneficially owned by Forbion Growth I and 6,035,034 shares are beneficially owned by Forbion IV.
表 I 有 1 筆交易的價格引用這則附註。